Prometheus Biosciences Inc
NASDAQ:RXDX
Prometheus Biosciences Inc
NASDAQ:RXDX
Price:
199.92 USD
0.09%
Market Closed
Updated:
Apr 30, 2024
Income Statement
Earnings Waterfall
Prometheus Biosciences Inc
Prometheus Biosciences Inc
|
Revenue
|
4m
USD
|
|
Operating Expenses
|
-166.4m
USD
|
|
Operating Income
|
-162.4m
USD
|
|
Other Expenses
|
11.8m
USD
|
|
Net Income
|
-150.6m
USD
|
Income Statement
Prometheus Biosciences Inc
Prometheus Biosciences Inc
Currency: USD
| Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||
| Revenue |
1
N/A
|
2
+93%
|
3
+50%
|
6
+101%
|
7
+15%
|
7
-1%
|
7
-5%
|
4
-41%
|
|
| Operating Income | |||||||||
| Operating Expenses |
(32)
|
(60)
|
(91)
|
(115)
|
(131)
|
(142)
|
(153)
|
(166)
|
|
| Selling, General & Administrative |
(11)
|
(21)
|
(29)
|
(31)
|
(35)
|
(35)
|
(40)
|
(45)
|
|
| Research & Development |
(21)
|
(39)
|
(62)
|
(83)
|
(95)
|
(106)
|
(113)
|
(121)
|
|
| Operating Income |
(31)
N/A
|
(58)
-86%
|
(88)
-52%
|
(108)
-23%
|
(123)
-14%
|
(134)
-9%
|
(146)
-8%
|
(162)
-11%
|
|
| Pre-Tax Income | |||||||||
| Interest Income Expense |
(1)
|
(1)
|
(1)
|
(0)
|
0
|
1
|
4
|
12
|
|
| Non-Reccuring Items |
0
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(33)
N/A
|
(60)
-83%
|
(90)
-50%
|
(108)
-20%
|
(123)
-14%
|
(133)
-8%
|
(142)
-7%
|
(151)
-6%
|
|
| Net Income | |||||||||
| Income from Continuing Operations |
(33)
|
(60)
|
(90)
|
(108)
|
(123)
|
(133)
|
(142)
|
(151)
|
|
| Net Income (Common) |
(33)
N/A
|
(60)
-83%
|
(90)
-50%
|
(108)
-20%
|
(123)
-14%
|
(133)
-8%
|
(142)
-7%
|
(151)
-6%
|
|
| EPS (Diluted) |
-0.85
N/A
|
-1.55
-82%
|
-2.32
-50%
|
-2.78
-20%
|
-3.15
-13%
|
-3.22
-2%
|
-3.29
-2%
|
-3.17
+4%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
